Spencer C. Fleischer - 31 Dec 2021 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Issuer symbol
CLX
Transactions as of
31 Dec 2021
Net transactions value
+$30,687
Form type
4
Filing time
04 Jan 2022, 15:18:04 UTC
Previous filing
18 Nov 2021
Next filing
28 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLX Common Stock Award $30,687 +176 +16% $174.36 1,305 31 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +67 +0.7% $0.000000 9,694 10 Nov 2021 Common Stock 67 Direct F2, F3, F4
transaction CLX Deferred Stock Units Award $0 +919 +9.5% $0.000000 10,612 31 Dec 2021 Common Stock 919 Direct F2, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Receipt of Common Stock in lieu of quarterly director's fee.
F2 1-for-1
F3 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F4 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F5 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.